Education
About Us
Working with TipRanks
Follow Us
DocMorris AG (CH:DOCM)
:DOCM
DOCM Analyst Ratings
Moderate Buy
4 Buy
5 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DOCM Stock 12 Month Forecast
Average Price Target
CHF18.20
▲(139.47%Upside)
| Highest Price TargetCHF40.00 | Average Price TargetCHF18.20 | Lowest Price TargetCHF10.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
CHF7.5
Sell
-1.32%
Downside
Downgraded
06/05/25
DocMorris presents a challenging investment profile primarily due to its weak financial performance, including declining revenues and profitability. Technical analysis further signals bearish trends, with the stock trading well below its moving averages. Additionally, valuation metrics are poor, highlighted by a negative P/E ratio. Despite some positive elements from the earnings call, such as strategic growth plans and increased Rx customers, these are overshadowed by the financial and technical challenges.
Jefferies
CHF15
Buy
97.37%
Upside
Reiterated
06/04/25
Baader Bank
CHF19→CHF10
Buy
31.58%
Upside
Upgraded
06/03/25
Hauck & Aufhaeuser
CHF60→CHF15
Buy
97.37%
Upside
Reiterated
05/27/25
Deutsche Bank
CHF20
Hold
163.16%
Upside
Reiterated
04/15/25
Stifel Nicolaus
CHF40
Buy
426.32%
Upside
Reiterated
04/10/25
Berenberg Bank
CHF24→CHF17
Hold
123.68%
Upside
Reiterated
03/19/25
Morgan Stanley
CHF22→CHF20
Hold
163.16%
Upside
Reiterated
03/18/25
UBS
CHF16
Sell
110.53%
Upside
Reiterated
03/13/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
CHF7.5
Sell
-1.32%
Downside
Downgraded
06/05/25
DocMorris presents a challenging investment profile primarily due to its weak financial performance, including declining revenues and profitability. Technical analysis further signals bearish trends, with the stock trading well below its moving averages. Additionally, valuation metrics are poor, highlighted by a negative P/E ratio. Despite some positive elements from the earnings call, such as strategic growth plans and increased Rx customers, these are overshadowed by the financial and technical challenges.
Jefferies
CHF15
Buy
97.37%
Upside
Reiterated
06/04/25
Baader Bank
CHF19→CHF10
Buy
31.58%
Upside
Upgraded
06/03/25
Hauck & Aufhaeuser
CHF60→CHF15
Buy
97.37%
Upside
Reiterated
05/27/25
Deutsche Bank
CHF20
Hold
163.16%
Upside
Reiterated
04/15/25
Stifel Nicolaus
CHF40
Buy
426.32%
Upside
Reiterated
04/10/25
Berenberg Bank
CHF24→CHF17
Hold
123.68%
Upside
Reiterated
03/19/25
Morgan Stanley
CHF22→CHF20
Hold
163.16%
Upside
Reiterated
03/18/25
UBS
CHF16
Sell
110.53%
Upside
Reiterated
03/13/25
Best Analysts Covering DocMorris
1 Month
xxx
Success Rate
23/40 ratings generated profit
Average Return
-0.80%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.50% of your transactions generating a profit, with an average return of -0.80% per trade.
3 Months
xxx
Success Rate
26/40 ratings generated profit
Average Return
+8.74%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +8.74% per trade.
1 Year
Success Rate
32/40 ratings generated profit
Average Return
+29.45%
reiterated a sell rating 3 months ago
Copying Sebastian Vogel's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +29.45% per trade.
2 Years
xxx
Success Rate
38/40 ratings generated profit
Average Return
+59.75%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 95.00% of your transactions generating a profit, with an average return of +59.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
DOCM Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
5
8
10
10
8
Buy
0
0
0
0
1
Hold
8
11
9
10
6
Sell
2
3
3
3
2
Strong Sell
0
0
0
0
0
total
15
22
22
23
17
Each month's total comprises the sum of three months' worth of ratings.
DOCM Financial Forecast
DOCM Stock Forecast FAQ
What is CH:DOCM’s average 12-month price target, according to analysts?
Based on analyst ratings, DocMorris AG’s 12-month average price target is 18.20.
What is CH:DOCM’s upside potential, based on the analysts’ average price target?
DocMorris AG has 139.47% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DocMorris AG a Buy, Sell or Hold?
DocMorris AG has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 5 hold ratings and 1 sell ratings.
What is DocMorris AG’s share price target?
The average share price target for DocMorris AG is 18.20. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF40.00 ,and the lowest forecast is CHF10.00. The average share price target represents 139.47% Increase from the current price of CHF7.6.
The highest analyst share price target is CHF40.00 ,and the lowest forecast is CHF10.00. The average share price target represents 139.47% Increase from the current price of CHF7.6.
What do analysts say about DocMorris AG?
DocMorris AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of DocMorris AG?
To buy shares of CH:DOCM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.